Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00681928 · ClinicalTrials.gov registry record
Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy
A clinical trial, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- 72
- Enrollment target
NCT00681928 is a clinical trial that has completed, run by City of Hope Medical Center. The registered enrollment target is 72 participants.
The verdict
NCT00681928 has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about cognitive function over time in postmenopausal women with breast cancer may help doctors learn about the long-term effects of aromatase inhibitor therapy and plan the best treatment. PURPOSE: This clinical trial is studying cognitive function in older postmenopausal women with stage I, stage II, or stage III breast cancer receiving hormone therapy and in healthy volunteers.
Interventions
- DRUG letrozole
- OTHER questionnaire administration
- DRUG anastrozole
- PROCEDURE cognitive assessment
- PROCEDURE psychosocial assessment and care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00681928
The ClinicalTrials.gov registry entry for NCT00681928 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which letrozole is the first listed.
NCT00681928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00681928 about?
NCT00681928 is a clinical study titled "Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy". RATIONALE: Gathering information about cognitive function over time in postmenopausal women with breast cancer may help doctors learn about the long-term effects of aromatase inhibitor therapy and plan the best treatment. PURPOSE: This clinical trial is studying cognitive function in older postmeno...
What is the current status of trial NCT00681928?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2007-10. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00681928?
The interventions under investigation include: letrozole (DRUG), questionnaire administration (OTHER), anastrozole (DRUG), cognitive assessment (PROCEDURE), psychosocial assessment and care (PROCEDURE).
Who is sponsoring clinical trial NCT00681928?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.